OPRM1 and rheumatoid arthritis: In this study, we evaluated the prophylactic effect of the peripherally-selective mu-opioid receptor (MOR) agonist, loperamide, administered topically in a liposomal gel formulation on pain, inflammation, and disease progression in the adjuvant-induced model of experimental RA.